Completed PHASE2 INTERVENTIONAL 2-arm NCT00606684

A Study To Assess Efficacy And Safety Of Different Doses Of GW642444 In Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Study B2C111045, A Dose-Finding Study of GW642444 Versus Placebo in Patients With COPD

Sponsor: GlaxoSmithKline

Conditions Pulmonary Disease, Chronic Obstructive

Interventions GW642444 12.5mcg GW642444 25mcg GW642444 3mcg GW642444 50mcg GW642444 6.25 placebo

Updated 8 times since 2017 Last updated: Nov 4, 2016 Started: Feb 29, 2008 Primary completion: Oct 31, 2008 Completion: Oct 31, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Pulmonary Disease, Chronic Obstructive and is currently completed. GlaxoSmithKline leads this study, which shows 8 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

8 versions recorded

Oct 2025 — Present [monthly]

Completed PHASE2
Sep 2025 — Oct 2025 [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2

▶ Show 3 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Feb 2017 — Jun 2018 [monthly]

Completed PHASE2
Jan 2017 — Feb 2017 [monthly]

Completed PHASE2

First recorded

Feb 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

GlaxoSmithKline

Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Abingdon, United States , Bathurst, Canada , Berlin, Germany , Brampton, Canada , Brandon, United States , Bratislava, Slovakia , Buenos Aires, Argentina , Butte, United States , Carmel, United States , Charleston, United States and 83 more locations